seastar.png
SeaStar Medical Activates 14th Hospital for its Adult AKI Pivotal Trial
December 23, 2024 07:00 ET | SeaStar Medical Holding Corporation
DENVER, Dec. 23, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary solutions to reduce the consequences of...
Logo 1200x628.jpg
CytoSorbents Unveils Newly Redesigned, Unified Company and Product Website
July 30, 2024 02:00 ET | CytoSorbents
CytoSorbents new modern website launch unifies corporate and product websites and highlights "Working to Save Lives Together"
Logo 1200x628.jpg
CytoSorbents Unveils Newly Redesigned, Unified Company and Product Website
July 29, 2024 08:00 ET | CytoSorbents
CytoSorbents new modern website launch unifies corporate and product websites and highlights "Working to Save Lives Together"
MnM_logo_TM_JPG.JPG
Continuous Renal Replacement Therapy Market is Expected to Reach $2.1 Billion | MarketsandMarkets.
December 19, 2023 18:30 ET | MarketsandMarkets Research Pvt. Ltd.
Chicago, Dec. 19, 2023 (GLOBE NEWSWIRE) -- Continuous Renal Replacement Therapy market in terms of revenue was estimated to be worth $1.4 Billion in 2023 and is poised to reach $2.1 billion by 2028,...
Continuous Renal Replacement Therapy (CRRT) Market
Continuous Renal Replacement Therapy (CRRT) Market Size to Surpass USD 1.76 Billion by 2030, exhibiting a CAGR of 7.8%
October 26, 2023 06:07 ET | Fortune Business Insights
Pune, India, Oct. 26, 2023 (GLOBE NEWSWIRE) -- Global Continuous Renal Replacement Therapy (CRRT) market size was valued at USD 1.01 billion in 2022 The market is anticipated to expand from USD 1.76...
MnM_logo_TM_JPG.JPG
Continuous Renal Replacement Therapy (CRRT) Market to Cross $1.7 billion by 2026 - Exclusive Report by MarketsandMarkets™
February 02, 2023 20:45 ET | MarketsandMarkets Research Pvt. Ltd.
Chicago, Feb. 02, 2023 (GLOBE NEWSWIRE) -- According to the new market research report Published by MarketsandMarkets, "Continuous Renal Replacement Therapy Market by Product (Disposables...
SeaStar_SM_LogoCard.png
SeaStar Medical’s Lead Product Candidate, the Selective Cytopheretic Device (SCD), Included in Consensus Statement for Pediatric Acute Kidney Injury in First Pediatric Acute Disease Quality Initiative (ADQI) Meeting
November 07, 2022 12:30 ET | SeaStar Medical Holding Corporation
– The SCD is currently being evaluated by the FDA for a Humanitarian Device Exemption (HDE) marketing approval for use in children (> 20 kgs) with AKI – The Company expects the FDA to complete...
Picture1.jpg
Nuwellis to Advance Treatment of Critically-Ill Children and Babies Under $1.7 Million NIH Grant
August 05, 2021 08:00 ET | Nuwellis, Inc.
EDEN PRAIRIE, Minn., Aug. 05, 2021 (GLOBE NEWSWIRE) -- Critically-ill children and babies with kidney failure or who are dependent on artificial kidney support currently do not have enough...
download (3).png
Jafron Biomedical Announces Global Advisory Board
June 21, 2021 07:00 ET | Jafron Biomedical Co.,Ltd.
ZHUHAI, China, June 21, 2021 (GLOBE NEWSWIRE) -- Jafron Biomedical, a pioneer in the blood purification industry, announced it's founding the Global Advisory Board, which includes the world’s top...